These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15388466)

  • 1. Dual-action mechanism of viramidine functioning as a prodrug and as a catabolic inhibitor for ribavirin.
    Wu JZ; Larson G; Hong Z
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4006-8. PubMed ID: 15388466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
    Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
    Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes.
    Wu JZ; Larson G; Walker H; Shim JH; Hong Z
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2164-71. PubMed ID: 15917509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers.
    Lin CC; Philips L; Xu C; Yeh LT
    J Clin Pharmacol; 2004 Mar; 44(3):265-75. PubMed ID: 14973309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for hepatitis C virus therapeutics: levovirin and viramidine as improved derivatives of ribavirin.
    Watson J
    Curr Opin Investig Drugs; 2002 May; 3(5):680-3. PubMed ID: 12090539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin.
    Wu JZ; Yeh LT; Lin CC; Hong Z
    Antivir Chem Chemother; 2006; 17(1):33-9. PubMed ID: 16542004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taribavirin in the treatment of hepatitis C.
    Deming P; Arora S
    Expert Opin Investig Drugs; 2011 Oct; 20(10):1435-43. PubMed ID: 21854301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection.
    Aora S; Xu C; Teng A; Peterson J; Yeh LT; Gish R; Lau D; Rossi S; Lin CC
    J Clin Pharmacol; 2005 Mar; 45(3):275-85. PubMed ID: 15703363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viramidine, a prodrug of ribavirin, shows better liver-targeting properties and safety profiles than ribavirin in animals.
    Lin CC; Yeh LT; Vitarella D; Hong Z
    Antivir Chem Chemother; 2003 May; 14(3):145-52. PubMed ID: 14521331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a new phosphorylated ribavirin prodrug.
    Dong SD; Lin CC; Schroeder M
    Antiviral Res; 2013 Jul; 99(1):18-26. PubMed ID: 23624267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ribavirin, levovirin and viramidine on liver toxicological gene expression in rats.
    Fang C; Srivastava P; Lin CC
    J Appl Toxicol; 2003; 23(6):453-9. PubMed ID: 14635270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, metabolism, and excretion of [14C]viramidine in humans.
    Lin CC; Xu C; Zhu N; Yeh LT
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2368-73. PubMed ID: 16801414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells.
    Yeh LT; Nguyen M; Dadgostari S; Bu W; Lin CC
    J Pharm Biomed Anal; 2007 Feb; 43(3):1057-64. PubMed ID: 17029670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive and specific LC-MS/MS method for the simultaneous measurements of viramidine and ribavirin in human plasma.
    Liu Y; Xu C; Yan R; Lim C; Yeh LT; Lin CC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):17-23. PubMed ID: 16455313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of purine nucleoside phosphorylase as a key enzyme in ribavirin metabolism.
    Furihata T; Kishida S; Sugiura H; Kamiichi A; Iikura M; Chiba K
    Drug Metab Pharmacokinet; 2014; 29(2):211-4. PubMed ID: 24107682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating HCV with ribavirin analogues and ribavirin-like molecules.
    Gish RG
    J Antimicrob Chemother; 2006 Jan; 57(1):8-13. PubMed ID: 16293677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2'-C-methylcytidine, the active component of valopicitabine.
    Coelmont L; Paeshuyse J; Windisch MP; De Clercq E; Bartenschlager R; Neyts J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3444-6. PubMed ID: 17005827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.
    Ruiz-Sanchis P; Wohl BM; Smith AA; Zuwala K; Melchjorsen J; Tolstrup M; Zelikin AN
    Adv Healthc Mater; 2015 Jan; 4(1):65-8. PubMed ID: 25132665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and deactivation of a broad-spectrum antiviral drug by a single enzyme: adenosine deaminase catalyzes two consecutive deamination reactions.
    Wu JZ; Walker H; Lau JY; Hong Z
    Antimicrob Agents Chemother; 2003 Jan; 47(1):426-31. PubMed ID: 12499231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viramidine (Ribapharm).
    Barnard D
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1585-9. PubMed ID: 12476957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.